| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Basecamp lifts veil on Trillion Gene Atlas genomics push | ||
| Mi | J&J gets FDA okay for psoriasis drug icotrokinra | ||
| Mi | First MHRA/NICE aligned guidance due in June | ||
| Mi | Hope rises for vaccine against hookworm parasite | ||
| Mi | US court says pharma giants must face False Claims suit | ||
| Di | Meningitis outbreak in UK prompts call to widen vaccination | ||
| Di | Alto raises $120m for resistant depression programme | ||
| Di | BioMarin halts Voxzogo trials due to safety signal | ||
| Di | Roche accelerates AI adoption with NVIDIA deal | ||
| Di | US judge rules Kennedy's vaccine changes 'unlawful' | ||
| Mo | AZ piles pressure on MSD et al in gastric cancer | ||
| Mo | Denying prostate cancer screening 'no longer rational' | ||
| Mo | Data builds behind Bayer's Kerendia in kidney disease | ||
| Mo | J&J says Inlexzo follow-up 'promising' in bladder cancer | ||
| Mo | GSK's RSV shot cleared in US for all adults | ||
| Fr | Regenxbio, Solid report data with Duchenne gene therapies | ||
| Fr | NHS hospitals 'should resist Palantir software rollout' | ||
| Fr | Immutep investors spooked by LAG-3 failure in lung cancer | ||
| Fr | Poll finds Americans cutting back elsewhere to fund health | ||
| 12.03. | Iran hackers claim cyberattack at US medtech firm | ||
| 12.03. | Ipsen appoints Michelle Werner as North America head | ||
| 12.03. | Evotec slashes staff as turnaround plan gathers pace | ||
| 12.03. | Eisai joins with Pokémon for sleep awareness drive | ||
| 12.03. | NVIDIA sinks $2bn into AI cloud provider Nebius | ||
| 11.03. | Novo rapped by FDA for not reporting drug adverse effects |